Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 8.80
0.00 (0.00%)
Oct 8, 2026, 2:58 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 265.59 million as of October 9, 2026. It is the 42,670th most valuable company in the world and the 2,331st biggest in Taiwan. Its market cap has decreased by 20.72% in one year.
Market Cap
265.59M
Enterprise Value
322.59M
Revenue
170.72M
Global Rank
Country Rank
#2,331 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 265.59M, a decrease of -70.45%. That is a compound annual growth rate of -8.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 265.59M | -9.28% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 774.68M |
| BioLASCO Taiwan | 729.94M |
| Neith | 703.95M |
| Taiwan Advance Bio-Pharmaceutical | 679.50M |
| Meribank Biotech | 649.74M |
| SynCore Biotechnology Co.,Ltd | 632.97M |
| TaiwanJ Pharmaceuticals | 564.06M |
| Vectorite Biomedical | 549.33M |